刘新泳山东大学主页平台管理系统--中文主页

Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2): 点击次数：; 所属单位：药学院; 发表刊物：Expert Opinion on Therapeutic Patents; 全部作者：展鹏,刘新泳; 第一作者：黄伯世; 论文类型：基础研究; 论文编号：C692CFAD379E4CF0B195D7F473EFF772; 卷号： 27; 期号：1; 页面范围：9; 是否译文：否; 发表时间：2017-01-01

上一条： 1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries

下一条： Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors